Immune therapy for ovarian cancer: Promise and pitfalls

Suzanne R. Thibodeaux, Tyler J Curiel

Research output: Contribution to journal › Article

16 Citations (Scopus)

Abstract

This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.

Original languageEnglish (US)
Pages (from-to)102-119
Number of pages18
JournalInternational Reviews of Immunology
Volume30
Issue number2-3
DOIs
StatePublished - Apr 2011

Fingerprint

Ovarian Neoplasms
Therapeutics

Keywords

  • immune therapy
  • immunity
  • Ovarian cancer
  • review

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Immune therapy for ovarian cancer : Promise and pitfalls. / Thibodeaux, Suzanne R.; Curiel, Tyler J.

In: International Reviews of Immunology, Vol. 30, No. 2-3, 04.2011, p. 102-119.

Research output: Contribution to journal › Article

Thibodeaux, SR & Curiel, TJ 2011, 'Immune therapy for ovarian cancer: Promise and pitfalls', International Reviews of Immunology, vol. 30, no. 2-3, pp. 102-119. https://doi.org/10.3109/08830185.2011.567361
Thibodeaux SR, Curiel TJ. Immune therapy for ovarian cancer: Promise and pitfalls. International Reviews of Immunology. 2011 Apr;30(2-3):102-119. https://doi.org/10.3109/08830185.2011.567361
Thibodeaux, Suzanne R. ; Curiel, Tyler J. / Immune therapy for ovarian cancer : Promise and pitfalls. In: International Reviews of Immunology. 2011 ; Vol. 30, No. 2-3. pp. 102-119.
@article{94380f3653dc428381ca4c6550c337ca,
title = "Immune therapy for ovarian cancer: Promise and pitfalls",
abstract = "This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.",
keywords = "immune therapy, immunity, Ovarian cancer, review",
author = "Thibodeaux, {Suzanne R.} and Curiel, {Tyler J}",
year = "2011",
month = "4",
doi = "10.3109/08830185.2011.567361",
language = "English (US)",
volume = "30",
pages = "102--119",
journal = "International Reviews of Immunology",
issn = "0883-0185",
publisher = "Informa Healthcare",
number = "2-3",

}

TY - JOUR

T1 - Immune therapy for ovarian cancer

T2 - Promise and pitfalls

AU - Thibodeaux, Suzanne R.

AU - Curiel, Tyler J

PY - 2011/4

Y1 - 2011/4

N2 - This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.

AB - This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.

KW - immune therapy

KW - immunity

KW - Ovarian cancer

KW - review

UR - http://www.scopus.com/inward/record.url?scp=79955828984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955828984&partnerID=8YFLogxK

U2 - 10.3109/08830185.2011.567361

DO - 10.3109/08830185.2011.567361

M3 - Article

C2 - 21557637

AN - SCOPUS:79955828984

VL - 30

SP - 102

EP - 119

JO - International Reviews of Immunology

JF - International Reviews of Immunology

SN - 0883-0185

IS - 2-3

ER -

Access to Document